Follow Us

       


"Like" us on Facebook

Clinical Trials

Disease or Condition
Cancer - Multiple Myeloma
Title
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma
Description
A Phase 1/2 Study of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma (PO-MM-PI-0049)
IRB Number
NCT01541332
Inclusion/Notes

Please contact the research department for full eligibility details. For additional information, please click here: http://clinicaltrials.gov/ct2/show/NCT01541332

Status
Open to Enrollment
Principal Investigator
Thomas B Woliver, MD
Contact Email
research@ccsb.org
Phone
(805) 898-2117

This is the fat footer - edit page 906 to add content.